Drug giant Eli Lilly has announced a $35 (£30) cap on the monthly costs patients face for insulin in the US, responding to outcry over the soaring cost of the diabetes medication. More than eight ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback